Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last hours
Enjoy this offer
* See conditions under "Our services"

Valuation: Takeda Pharmaceutical Company Limited

Market Cap 7,958B 49.43B 43.07B 39.7B 37.35B 69.87B 4,659B 70.36B 472B 183B 2,296B 186B 182B P/E 2026
46.4x
P/E 2027 * 41x
Enterprise Value 11,897B 73.91B 64.39B 59.36B 55.83B 104B 6,965B 105B 706B 274B 3,433B 277B 271B EV / Sales 2026
1.14x
EV / Sales 2027 * 2.56x
Free-Float
99.25%
Yield 2026
3.53%
Yield 2027 * 4.06%
1 day-1.57%
1 week-2.44%
Current month-3.13%
1 month-5.65%
3 months-14.04%
6 months+7.69%
Current year+2.54%
1 week 4,909
Extreme 4909
5,158
1 month 4,710
Extreme 4710
5,362
Current year 4,710
Extreme 4710
6,033
1 year 4,102
Extreme 4102
6,033
3 years 3,852
Extreme 3852
6,033
5 years 2,993
Extreme 2993
6,033
10 years 2,894.5
Extreme 2894.5
6,693
Manager TitleAgeSince
Chief Executive Officer 59 2015-03-31
Director of Finance/CFO 48 2024-03-31
Chief Tech/Sci/R&D Officer 47 2022-01-31
Director TitleAgeSince
Director/Board Member 59 2014-05-31
Director/Board Member 60 2015-05-31
Director/Board Member 74 2016-05-31
Date Insider Type Main position Quantity % Market Cap.
04-26Free

Chief Technology Officer

212,470 0.0134%
04-26Free

Chief Financial Officer

15,614 0.0010%
04-26Free

Chief Executive Officer

323,248 0.0203%
Change 5-day change 1-year change 3-year change Capi.($)
-1.63%-2.44%+15.36%+6.97% 48.69B
-1.21%-5.37%+39.94%+145.38% 992B
-2.48%-4.17%+51.52%+39.07% 564B
-2.14%-3.68%+16.71%+56.15% 391B
-1.18%+0.25%+25.86%+16.53% 330B
-2.36%-3.12%+24.71%+11.59% 280B
-2.45%-2.88%+24.29%+30.06% 279B
-1.91%-0.87%-41.95%-49.25% 196B
-1.19%-4.65%+16.56%+47.00% 184B
-1.35%-1.68%+14.59%+56.94% 156B
Average -1.78%-2.05%+18.76%+36.04% 341.99B
Weighted average by Cap. -1.77%-2.88%+27.85%+62.41%

Financials

2026 2027 *
Net sales 4,531B 28.15B 24.53B 22.61B 21.27B 39.78B 2,653B 40.06B 269B 104B 1,307B 106B 103B 4,630B 28.76B 25.06B 23.1B 21.73B 40.65B 2,711B 40.94B 275B 107B 1,336B 108B 106B
Net income 174B 1.08B 944M 870M 819M 1.53B 102B 1.54B 10.36B 4.02B 50.34B 4.07B 3.98B 184B 1.14B 995M 918M 863M 1.61B 108B 1.63B 10.92B 4.24B 53.06B 4.29B 4.2B
Net Debt 3,940B 24.47B 21.32B 19.66B 18.49B 34.59B 2,306B 34.83B 234B 90.82B 1,137B 91.86B 89.89B 3,914B 24.32B 21.19B 19.53B 18.37B 34.37B 2,292B 34.61B 232B 90.24B 1,129B 91.27B 89.32B
Logo Takeda Pharmaceutical Company Limited
Takeda Pharmaceutical Co Ltd is a Japan-based company mainly engaged in the research, development, manufacturing and global sales of a wide range of pharmaceuticals. Its main business areas are divided into six, including gastroenterology, rare diseases, plasma-derived therapies, oncology (cancer), vaccines, and neuroscience (neuropsychiatric disorders). In research and development, the Company focuses on three priority disease areas, including gastroenterology and inflammatory diseases, neuroscience, and oncology, and also focuses on plasma-derived therapies.
Employees
47,455
Date Price Change Volume
26-06-18 4,955.00 ¥ -1.63% 1,098,000
26-06-18 5,037.00 ¥ +2.00% 3,465,300
26-06-17 4,938.00 ¥ -1.63% 3,890,400
26-06-16 5,020.00 ¥ -1.34% 3,072,600
26-06-15 5,088.00 ¥ +0.12% 3,450,400
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
15
Last Close Price
5,037.00JPY
Average target price
6,086.87JPY
Spread / Average Target
+20.84%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 4502 Stock
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!